Skip to main content
Clinical Trials/JPRN-jRCT1080220056
JPRN-jRCT1080220056
Unknown
Phase 3

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC).

Taiho Pharmaceutical Co., Ltd.0 sitesSeptember 7, 2005
ConditionsBowel cancer

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Bowel cancer
Sponsor
Taiho Pharmaceutical Co., Ltd.
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2005
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with Dukes C bower cancer who received a surgery of curative resection (curability A).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials